• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《简短炎症性肠病问卷:用于社区医生管理炎症性肠病的生活质量工具》。CCRPT研究人员。加拿大克罗恩病复发预防试验。

The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial.

作者信息

Irvine E J, Zhou Q, Thompson A K

机构信息

Department of Medicine, McMaster University, Hamilton, Ontario.

出版信息

Am J Gastroenterol. 1996 Aug;91(8):1571-8.

PMID:8759664
Abstract

OBJECTIVE

Health-related quality of life (HRQOL) affects outcome in chronic diseases such as inflammatory bowel disease (IBD). The inflammatory bowel disease questionnaire (IBDQ), a disease-specific HRQOL questionnaire, can define changes in health status in IBD, but simple instruments are needed for daily application. The present study proposed to develop a short version of the IBDQ, the SIBDQ, for community physicians.

METHODS

Using data from a clinical trial in 149 patients with Crohn's disease, 10 items were selected (by forward stepwise regression) that best explained the variance of the IBDQ or dimensional scores (bowel, systemic, social, emotional). The validity, reliability, and responsiveness of the SIBDQ were then assessed in 150 different patients with Crohn's disease and 45 with ulcerative colitis. All scores were reported with a 7-point scale (1 = poor HRQOL, 7 = optimum HRQOL).

RESULTS

Mean SIBDQ scores were similar (p = 0.22) in Crohn's patients among 14 participating centers at study entry. Mean scores were lower in active Crohn's disease (range 4.00-4.92) than inactive disease (range 4.67-5.83; p = 0.0015). In active ulcerative colitis, the mean SIBDQ was 4.79 +/- 1.17 compared to 5.90 +/- 0.80 (p = 0.0006) in inactive disease. The SIBDQ explained 92% and 90% of the IBDQ variance in Crohn's disease and ulcerative colitis, respectively. In patients with stable Crohn's disease, the test-retest reliability coefficient was 0.65 and Crohnbach's alpha was 0.78, indicating good reliability. In patients with Crohn's disease who relapsed during follow-up, the mean SIBDQ decreased by -0.93 + 0.55 (p = 0.001).

CONCLUSION

The SIBDQ is valid, reliable, and able to detect meaningful clinical changes in HRQOL that might occur in the office setting.

摘要

目的

健康相关生活质量(HRQOL)会影响炎症性肠病(IBD)等慢性病的预后。炎症性肠病问卷(IBDQ)是一种针对特定疾病的HRQOL问卷,可界定IBD患者健康状况的变化,但日常应用需要简单的工具。本研究旨在为社区医生开发一种IBDQ的简短版本,即SIBDQ。

方法

利用一项针对149例克罗恩病患者的临床试验数据,通过向前逐步回归选择了10个能最好解释IBDQ或维度得分(肠道、全身、社会、情感)方差的项目。随后在150例不同的克罗恩病患者和45例溃疡性结肠炎患者中评估了SIBDQ的有效性、可靠性和反应性。所有得分均采用7分制(1 = HRQOL差,7 = HRQOL最佳)。

结果

在研究开始时,14个参与中心的克罗恩病患者的SIBDQ平均得分相似(p = 0.22)。活动期克罗恩病的平均得分(范围4.00 - 4.92)低于非活动期疾病(范围4.67 - 5.83;p = 0.0015)。在活动期溃疡性结肠炎中,SIBDQ平均分为4.79±1.17,而非活动期疾病为5.90±0.80(p = 0.0006)。SIBDQ分别解释了克罗恩病和溃疡性结肠炎中IBDQ方差的92%和90%。在病情稳定的克罗恩病患者中,重测信度系数为0.65,克朗巴赫α系数为0.78,表明可靠性良好。在随访期间复发的克罗恩病患者中,SIBDQ平均分下降了-0.93 + 0.55(p = 0.001)。

结论

SIBDQ有效、可靠,能够检测在门诊环境中可能发生的HRQOL有意义的临床变化。

相似文献

1
The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial.《简短炎症性肠病问卷:用于社区医生管理炎症性肠病的生活质量工具》。CCRPT研究人员。加拿大克罗恩病复发预防试验。
Am J Gastroenterol. 1996 Aug;91(8):1571-8.
2
The short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis.简短炎症性肠病问卷对溃疡性结肠炎临床上的重要变化具有可靠性和反应性。
Am J Gastroenterol. 2001 Oct;96(10):2921-8. doi: 10.1111/j.1572-0241.2001.04682.x.
3
Evaluation of the Inflammatory Bowel Disease Questionnaire in Swedish patients with Crohn's disease.炎症性肠病问卷在瑞典克罗恩病患者中的评估
Scand J Gastroenterol. 2006 Aug;41(8):934-43. doi: 10.1080/00365520500529488.
4
[Validation of the new German translation version of the "Short Inflammatory Bowel Disease Questionnaire" (SIBDQ)].["《简短炎症性肠病问卷》(SIBDQ)新德文翻译版本的验证"]
Z Gastroenterol. 2000 Apr;38(4):277-86. doi: 10.1055/s-2000-14868.
5
Validation of the spanish version of the inflammatory bowel disease questionnaire on ulcerative colitis and Crohn's disease.炎症性肠病问卷西班牙语版在溃疡性结肠炎和克罗恩病方面的验证
Digestion. 1999;60(3):274-80. doi: 10.1159/000007670.
6
[Validation of the German version of the Inflammatory Bowel Disease Questionnaire (Competence Network IBD, IBDQ-D)].[炎症性肠病问卷德语版(炎症性肠病能力网络,IBDQ-D)的验证]
Psychother Psychosom Med Psychol. 2006 Jul;56(7):291-8. doi: 10.1055/s-2006-932661. Epub 2006 May 22.
7
Validation of the inflammatory bowel disease questionnaire IBDQ-D, German version, for patients with ileal pouch anal anastomosis for ulcerative colitis.溃疡性结肠炎回肠储袋肛管吻合术患者炎症性肠病问卷IBDQ-D德文版的验证
Z Gastroenterol. 2004 Feb;42(2):131-9. doi: 10.1055/s-2004-812835.
8
Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease.心理障碍和炎症性肠病的严重程度可预测溃疡性结肠炎和克罗恩病患者与健康相关的生活质量。
Am J Gastroenterol. 2002 Aug;97(8):1994-9. doi: 10.1111/j.1572-0241.2002.05842.x.
9
The SIBDQ: further validation in ulcerative colitis patients.炎症性肠病患者生活质量问卷(SIBDQ):在溃疡性结肠炎患者中的进一步验证
Am J Gastroenterol. 2000 Jan;95(1):145-51. doi: 10.1111/j.1572-0241.2000.01676.x.
10
[Quality of life in chronic inflammatory bowel diseases. Validation of a questionnaire and first French data].[慢性炎症性肠病的生活质量。一份问卷的验证及首批法国数据]
Gastroenterol Clin Biol. 1996;20(12):1071-7.

引用本文的文献

1
Disease Burden and Unmet Medical Needs in Patients with Ulcerative Colitis in Greece: A Cross-Sectional Patient Survey.希腊溃疡性结肠炎患者的疾病负担和未满足的医疗需求:一项横断面患者调查。
Med Sci (Basel). 2025 Aug 8;13(3):117. doi: 10.3390/medsci13030117.
2
Benchmarks after bowel resection in Crohn's disease: implementing clinically meaningful health-related quality of life targets.克罗恩病肠道切除术后的基准:实施具有临床意义的健康相关生活质量目标。
Surg Endosc. 2025 Jul 23. doi: 10.1007/s00464-025-11983-z.
3
iACT4IBD: a randomised controlled trial of a brief online intervention based on acceptance and commitment therapy to improve wellbeing for adults with inflammatory bowel disease.
iACT4IBD:一项基于接纳与承诺疗法的简短在线干预对改善炎症性肠病成年患者幸福感的随机对照试验。
Front Digit Health. 2025 Jun 26;7:1587765. doi: 10.3389/fdgth.2025.1587765. eCollection 2025.
4
Health-related quality of life outcomes among vedolizumab-treated patients with inflammatory bowel disease in the UK and Ireland: a 52-week observational study (OCTAVO).在英国和爱尔兰接受维多珠单抗治疗的炎症性肠病患者的健康相关生活质量结果:一项52周的观察性研究(OCTAVO)。
J Patient Rep Outcomes. 2025 Jul 1;9(1):80. doi: 10.1186/s41687-025-00846-9.
5
Validation of the Portuguese Version of IBD-Control Questionnaire and Comparison with IBD-Disk.葡萄牙语版炎症性肠病控制问卷的验证及与炎症性肠病诊断盘的比较。
GE Port J Gastroenterol. 2024 Oct 2;32(3):185-196. doi: 10.1159/000541219. eCollection 2025 Jun.
6
Impact of Depression on Health-Related Quality of Life in Ulcerative Colitis Patients-Are We Doing Enough? A Single Tertiary Center Experience.抑郁症对溃疡性结肠炎患者健康相关生活质量的影响——我们做得够吗?一项单三级中心经验。
Life (Basel). 2025 Apr 6;15(4):612. doi: 10.3390/life15040612.
7
Complete mucosal healing prevents stricture progression after endoscopic balloon dilation in Crohn's disease.在克罗恩病中,完全黏膜愈合可防止内镜下球囊扩张术后狭窄进展。
DEN Open. 2025 Apr 23;5(1):e70121. doi: 10.1002/deo2.70121. eCollection 2025 Apr.
8
Psychological interventions for treatment of inflammatory bowel disease.用于治疗炎症性肠病的心理干预措施。
Cochrane Database Syst Rev. 2025 Apr 17;4(4):CD006913. doi: 10.1002/14651858.CD006913.pub3.
9
Quality of life and burden of disease in a Mexican population with inflammatory bowel disease: an analysis of the RISE-MX trial.墨西哥炎症性肠病患者的生活质量和疾病负担:RISE-MX试验分析
Therap Adv Gastroenterol. 2025 Mar 19;18:17562848251318032. doi: 10.1177/17562848251318032. eCollection 2025.
10
Multimodal Lifestyle Intervention Improves Fatigue in Quiescent Inflammatory Bowel Disease: A Controlled Study.多模式生活方式干预改善静止期炎症性肠病患者的疲劳:一项对照研究。
Crohns Colitis 360. 2025 Feb 8;7(1):otaf009. doi: 10.1093/crocol/otaf009. eCollection 2025 Jan.